Daiichi Life Insurance Co. Ltd. Makes New Investment in Danaher Corporation $DHR

Daiichi Life Insurance Co. Ltd. purchased a new stake in Danaher Corporation (NYSE:DHR) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 30,954 shares of the conglomerate’s stock, valued at approximately $5,896,000.

Several other large investors have also recently modified their holdings of DHR. Main Street Group LTD bought a new stake in shares of Danaher in the first quarter worth $25,000. N.E.W. Advisory Services LLC bought a new position in Danaher during the 2nd quarter worth $25,000. JPL Wealth Management LLC bought a new position in Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC acquired a new position in Danaher during the 2nd quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher during the 4th quarter worth about $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $219.42 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The business has a 50-day moving average price of $195.80 and a two-hundred day moving average price of $192.61. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a market cap of $154.25 billion, a P/E ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue was up 5.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 EPS. As a group, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analysts Forecast Growth

DHR has been the subject of several recent research reports. Royal Bank Of Canada increased their price target on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. TD Cowen cut their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, DZ Bank started coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.